The incidence and risk factors of hypofibrinogenemia in cardiovascular surgery.
Afibrinogenemia
/ blood
Aged
Aged, 80 and over
Aorta
/ surgery
Cardiac Surgical Procedures
/ adverse effects
Coronary Artery Bypass
/ adverse effects
Female
Fibrinogen
/ biosynthesis
Heart Valves
/ surgery
Hemorrhage
Humans
Incidence
Intraoperative Period
Male
Middle Aged
Odds Ratio
Postoperative Complications
ROC Curve
Retrospective Studies
Risk Factors
Vascular Surgical Procedures
/ adverse effects
Cardiovascular surgery
Coagulopathy
Fibrinogen
Hemostasis
Journal
General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
16
03
2019
accepted:
04
09
2019
pubmed:
19
9
2019
medline:
6
10
2020
entrez:
19
9
2019
Statut:
ppublish
Résumé
Cardiovascular surgery often causes massive bleeding due to coagulopathy, with hypofibrinogenemia being a major causative factor. We assessed the intraoperative incidence of hypofibrinogenemia and explored predictors of hypofibrinogenemia. The intraoperative serum fibrinogen level (SFL) was routinely measured in 872 consecutive patients [mean age: 66.9 ± 13.3 years; 598 men (68.6%)] undergoing cardiovascular surgery from July 2013 to November 2016 at Nagoya University Hospital. There were 275 aortic surgeries, 200 cases of coronary artery bypass grafting (CABG), 334 valvular surgeries and 63 other surgeries. We estimated hypofibrinogenemia incidence (intraoperative lowest SFL ≤ 150 mg/dL) and identified its predictors by a logistic regression analysis. The average intraoperative lowest SFL of all cases, aortic surgery, CABG and valvular surgery was 185 ± 71, 156 ± 65, 198 ± 69 and 198 ± 68 mg/dL, respectively. Aortic surgery had a significantly lower intraoperative lowest SFL than CABG (p < 0.001) and valvular surgery (p < 0.001). The incidence of hypofibrinogenemia was 32.8%, 50.2%, 26.5% and 22.8% in all cases, aortic surgery, CABG and valvular surgery, respectively. The predictors of hypofibrinogenemia were the preoperative SFL, re-do surgery and perfusion time. A receiver operating characteristics curve analysis showed that the best preoperative SFL cutoff value for predicting hypofibrinogenemia was 308.5 mg/dL. Assuming preoperative SFL 300 mg/dL as the cutoff, the odds ratio for hypofibrinogenemia was 7.22 (95% confidence interval 5.26-9.92, p < 0.001). The incidence of hypofibrinogenemia in aortic surgery was high. The preoperative SFL, re-do surgery and perfusion time were identified as predictors for hypofibrinogenemia. Intraoperative measurement of SFL is important for detecting hypofibrinogenemia and applying appropriate and prompt transfusion treatment.
Identifiants
pubmed: 31531835
doi: 10.1007/s11748-019-01201-8
pii: 10.1007/s11748-019-01201-8
doi:
Substances chimiques
Fibrinogen
9001-32-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
335-341Références
J Thorac Cardiovasc Surg. 2009 Sep;138(3):694-702
pubmed: 19698858
Ann Thorac Cardiovasc Surg. 2019 Jun 20;25(3):142-148
pubmed: 30568075
Thromb Haemost. 2015 Apr;113(4):759-71
pubmed: 25502954
Transfusion. 2009 Sep;49(9):2006-7; author reply 2007-8
pubmed: 19735504
Immunohematology. 2011;27(4):151-3
pubmed: 22646071
J Thorac Cardiovasc Surg. 2013 Mar;145(3 Suppl):S178-85
pubmed: 23410777
Transfusion. 2014 May;54(5):1389-405; quiz 1388
pubmed: 24117955
J Thorac Cardiovasc Surg. 2014 Oct;148(4):1647-55
pubmed: 24951020
Ann Thorac Surg. 2014 Apr;97(4):1199-206
pubmed: 24507940
Nagoya J Med Sci. 2015 Feb;77(1-2):265-73
pubmed: 25797992
Anesthesiology. 2013 Jan;118(1):40-50
pubmed: 23249928
Clin Appl Thromb Hemost. 2018 Sep;24(6):998-1004
pubmed: 29050500
Transfusion. 2014 Jan;54(1):109-18
pubmed: 23718572
Clin Appl Thromb Hemost. 2011 Aug;17(4):396-404
pubmed: 20530054
Br J Anaesth. 2009 Jun;102(6):785-92
pubmed: 19411671
Anaesth Intensive Care. 2000 Aug;28(4):420-6
pubmed: 10969370
Anesth Analg. 2018 Feb;126(2):425-434
pubmed: 28682954
Br J Anaesth. 2013 Jun;110(6):947-56
pubmed: 23388508
Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):292-8
pubmed: 24316606
J Cardiothorac Surg. 2014 May 19;9:90
pubmed: 24884627
Transfusion. 2008 Oct;48(10):2152-8
pubmed: 18657083
J Cardiothorac Vasc Anesth. 1997 Dec;11(7):824-7
pubmed: 9412877
J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1196-204
pubmed: 27493092